T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production

Zsolt Illés, Hanspeter Waldner, N R Jayagopala Reddy, Estelle Bettelli, Lindsay B. Nicholson, Vijay K. Kuchroo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cross-reactive activation of potentially autoreactive T cells by high-affinity nonself ligands may be important in breaking self-tolerance in autoimmunity. In a mouse transgenic for a cross-reactive TCR, we have previously shown that a hyperstimulating altered peptide ligand, L144, induced unresponsiveness to the self peptide, proteolipid protein 139-151. In this study, we demonstrate that a superagonist ligand can break T cell tolerance induced by the lower affinity cognate Ag. T cells tolerant to the cognate ligand, Q144, responded to superagonist, L144, by proliferation and the production of mainly IL-4 and IL-10 in vitro. In contrast, T cells that were tolerized to the superagonist were unable to respond to any peptide that cross-reacted with the transgenic TCR. Low-dose immunization with the superagonist L144 was able to break tolerance to the cognate ligand in vivo and resulted in a blunted proliferative response with production of Th2 cytokines.

Original languageEnglish (US)
Pages (from-to)1491-1497
Number of pages7
JournalJournal of Immunology
Volume175
Issue number3
DOIs
StatePublished - Aug 1 2005

Fingerprint

Anti-Inflammatory Agents
Cytokines
Ligands
T-Lymphocytes
Peptides
Self Tolerance
Autoimmunity
Interleukin-4
Interleukin-10
Transgenic Mice
Immunization
Thomsen-Friedenreich antibodies

ASJC Scopus subject areas

  • Immunology

Cite this

T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production. / Illés, Zsolt; Waldner, Hanspeter; Reddy, N R Jayagopala; Bettelli, Estelle; Nicholson, Lindsay B.; Kuchroo, Vijay K.

In: Journal of Immunology, Vol. 175, No. 3, 01.08.2005, p. 1491-1497.

Research output: Contribution to journalArticle

Illés, Zsolt ; Waldner, Hanspeter ; Reddy, N R Jayagopala ; Bettelli, Estelle ; Nicholson, Lindsay B. ; Kuchroo, Vijay K. / T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production. In: Journal of Immunology. 2005 ; Vol. 175, No. 3. pp. 1491-1497.
@article{c1f0ae38588f474dbdf3159117b3c2b3,
title = "T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production",
abstract = "Cross-reactive activation of potentially autoreactive T cells by high-affinity nonself ligands may be important in breaking self-tolerance in autoimmunity. In a mouse transgenic for a cross-reactive TCR, we have previously shown that a hyperstimulating altered peptide ligand, L144, induced unresponsiveness to the self peptide, proteolipid protein 139-151. In this study, we demonstrate that a superagonist ligand can break T cell tolerance induced by the lower affinity cognate Ag. T cells tolerant to the cognate ligand, Q144, responded to superagonist, L144, by proliferation and the production of mainly IL-4 and IL-10 in vitro. In contrast, T cells that were tolerized to the superagonist were unable to respond to any peptide that cross-reacted with the transgenic TCR. Low-dose immunization with the superagonist L144 was able to break tolerance to the cognate ligand in vivo and resulted in a blunted proliferative response with production of Th2 cytokines.",
author = "Zsolt Ill{\'e}s and Hanspeter Waldner and Reddy, {N R Jayagopala} and Estelle Bettelli and Nicholson, {Lindsay B.} and Kuchroo, {Vijay K.}",
year = "2005",
month = "8",
day = "1",
doi = "10.4049/jimmunol.175.3.1491",
language = "English (US)",
volume = "175",
pages = "1491--1497",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production

AU - Illés, Zsolt

AU - Waldner, Hanspeter

AU - Reddy, N R Jayagopala

AU - Bettelli, Estelle

AU - Nicholson, Lindsay B.

AU - Kuchroo, Vijay K.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Cross-reactive activation of potentially autoreactive T cells by high-affinity nonself ligands may be important in breaking self-tolerance in autoimmunity. In a mouse transgenic for a cross-reactive TCR, we have previously shown that a hyperstimulating altered peptide ligand, L144, induced unresponsiveness to the self peptide, proteolipid protein 139-151. In this study, we demonstrate that a superagonist ligand can break T cell tolerance induced by the lower affinity cognate Ag. T cells tolerant to the cognate ligand, Q144, responded to superagonist, L144, by proliferation and the production of mainly IL-4 and IL-10 in vitro. In contrast, T cells that were tolerized to the superagonist were unable to respond to any peptide that cross-reacted with the transgenic TCR. Low-dose immunization with the superagonist L144 was able to break tolerance to the cognate ligand in vivo and resulted in a blunted proliferative response with production of Th2 cytokines.

AB - Cross-reactive activation of potentially autoreactive T cells by high-affinity nonself ligands may be important in breaking self-tolerance in autoimmunity. In a mouse transgenic for a cross-reactive TCR, we have previously shown that a hyperstimulating altered peptide ligand, L144, induced unresponsiveness to the self peptide, proteolipid protein 139-151. In this study, we demonstrate that a superagonist ligand can break T cell tolerance induced by the lower affinity cognate Ag. T cells tolerant to the cognate ligand, Q144, responded to superagonist, L144, by proliferation and the production of mainly IL-4 and IL-10 in vitro. In contrast, T cells that were tolerized to the superagonist were unable to respond to any peptide that cross-reacted with the transgenic TCR. Low-dose immunization with the superagonist L144 was able to break tolerance to the cognate ligand in vivo and resulted in a blunted proliferative response with production of Th2 cytokines.

UR - http://www.scopus.com/inward/record.url?scp=22544474149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544474149&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.175.3.1491

DO - 10.4049/jimmunol.175.3.1491

M3 - Article

C2 - 16034086

AN - SCOPUS:22544474149

VL - 175

SP - 1491

EP - 1497

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -